can glp 1 cause heart issues Glucagon-Like Peptide-1 Agonist Use in Adults With Congenital Disease: Effect, Safety, and Outcomes GLP-1RAs reduce cardiovascular deaths in
Description
Improved body composition
It acts as a bispecific molecule, combining GLP-1 receptor agonism with GIP receptor antagonism to promote weight loss
And its not just about smaller portions
Studies published in English with treatment duration 12 weeks and information on HbA1c changes were included
